144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort

INTRODUCTION: STAR/STELLA is a prospective[TS1] cohort of HIV patients initiated on LPV/r-based ART in routine clinical practice. Here, virologic/immunologic outcomes and safety data of LPV/r-based first-line ART over a period of 144 weeks are presented. METHODS: Analysis included ART-naïve patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Eva, Trein, Andreas, Baumgarten, Axel, Stephan, Christoph, Jaeger, Hans, Hillenbrand, Heribert, Koeppe, Siegfried, Lutz, Thomas, Koenig, Bettina, Stellbrink, Hans-Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P238
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225449/
https://www.ncbi.nlm.nih.gov/pubmed/25397514
http://dx.doi.org/10.7448/IAS.17.4.19770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225449/
https://www.ncbi.nlm.nih.gov/pubmed/25397514
http://dx.doi.org/10.7448/IAS.17.4.19770

Ejemplares similares